Influx Healthtech IPO 2025: Opening/Closing Date,Price

The Influx Healthtech Limited IPO opens on June 18, 2025, presenting investors with an opportunity to participate in India's healthcare and cosmetics contract manufacturing sector. With increasing demand for outsourcing in healthcare and personal care manufacturing and the company's strategic position as a specialized CDMO (Contract Development and Manufacturing Organization), this SME IPO comes at an opportune time in India's evolving pharmaceutical and healthcare landscape.

IPO Dates for Influx Healthtech

The Influx Healthtech IPO date is June 18, 2025 and the close date is June 20, 2025. The Influx Healthtech IPO allotment will be finalized on June 23, 2025 and the IPO listing on June 25, 2025.

Influx Healthtech IPO Market Lot

The Influx Healthtech IPO minimum market lot is 1,200 shares with ₹1,15,200 application amount at the upper price band.

IPO Details Summary

About Influx Healthtech IPO

Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries. Founded by Munir Chandniwala, the company operates as a contract-based manufacturer of cosmetics and healthcare products, serving various sectors including pharmaceuticals, personal care, and wellness industries.

Financial Performance of Influx Healthtech

The company has demonstrated strong growth and profitability in India's expanding healthcare and cosmetics manufacturing sector.

Amount ₹ in Crores

Performance Analysis

Influx Healthtech Limited has positioned itself strategically in India's growing contract manufacturing sector for healthcare and cosmetics. The company has three manufacturing facilities in Thane, Maharashtra, demonstrating its commitment to meeting increasing demand for outsourced manufacturing services in the healthcare and personal care sectors.

Influx Healthtech IPO Share Reservation

The Influx Healthtech IPO is a bookbuilding offering of 61.00 lakh shares valued at ₹58.57 crores that comprises fresh issue of ₹48.00 crores and offer for sale up to 11,00,400 equity shares. NSE SME will list shares of Influx Healthtech Limited.

Sector Comparison

Know Before Investing

Risks

• Industry Competition: Intense competition in contract manufacturing sector with established players and new entrants.

• Regulatory Compliance: Healthcare and cosmetics manufacturing subject to strict regulatory requirements and quality standards.

• Client Concentration: Potential dependence on large pharmaceutical and cosmetics companies for revenue stability.

• Raw Material Dependency: Dependence on chemical and pharmaceutical raw materials affecting cost structure.

• Technology Evolution: Need for continuous upgrades in manufacturing technology and quality systems.

• SME Platform Risks: Lower liquidity and higher volatility compared to mainboard stocks.

• Scalability Challenges: Capital requirements for expanding manufacturing capacity and meeting growing demand.

Strengths

• Strong Profitability: Consistent profit growth with PAT increasing from ₹7.2 crores in FY23 to ₹13.4 crores in FY25.

• Revenue Growth: Steady revenue increase from ₹76.1 crores in FY23 to ₹105.0 crores in FY25.

• Low Debt Profile: Minimal borrowings of ₹0.2 crores indicating strong financial discipline.

• Growing Net Worth: Net worth doubled from ₹11.7 crores in FY23 to ₹36.2 crores in FY25.

• CDMO Expertise: Specialized knowledge in contract development and manufacturing for healthcare sector.

• Multiple Facilities: Three manufacturing facilities in Thane, Maharashtra providing operational flexibility.

• Market Opportunity: Benefits from increasing outsourcing trends in pharmaceutical and cosmetics industries.

• Experienced Leadership: Founded by experienced entrepreneur Munir Chandniwala with industry expertise.

How to Apply for Influx Healthtech IPO?

Step-by-step guide on how to apply for the Influx Healthtech IPO:

--> Login to your broker app (Zerodha, Angel One, Groww, etc.)

--> Go to the IPO section and select Influx Healthtech IPO

--> Click "Apply"

--> Enter:

• Lot size (min. 1 lot = 1,200 shares)

• Bid price (₹91–₹96 or select Cut-Off)

• Your UPI ID

--> Submit the application

--> Approve the UPI mandate in your UPI app (PhonePe, GPay, etc.)

⏰ Important: Mandate must be approved before 5 PM on the same day or before IPO closes (June 20).

How to Check Influx Healthtech IPO Allotment Status?

You can check for Influx Healthtech IPO allotment through NSE or BSE and the registrar portal.

Check On NSE

1. Visit the NSE or BSE Official Website

2. Navigate to the IPO Allotment Section

3. Select Equity as the issue type

4. Choose Influx Healthtech IPO

5. Choose whether to proceed with the PAN number or application number

6. Submit your details to get the allotment status online

Check On Registrar Portal

1. Visit the Maashitla Securities official website

2. Select IPO allotment status

3. Choose Influx Healthtech IPO

4. Enter PAN or application number

5. Submit to check status

Company Address & IPO Registrar

Name : Influx Healthtech Limited

Address : 109, Ghanshyam Enclave Premises Co-op, Soc Plot No. 856, Laljipada, Kandivali West, Mumbai, Maharashtra

Phone : +91 7045997809

Email : cs@influxhealthtech.com

Website : https://influxhealthtech.com/

IPO Registrar

Name : Maashitla Securities Private Limited

Address : Maashitla Securities Private Limited 451, Krishna Apra Business Square Netaji Subhash Place Pitampura, Delhi, 110034

Phone : +91114512179596

Email : Investor.ipo@maashitla.com

Website : https://maashitla.com/allotment-status/public-issues

Conclusion

Influx Healthtech stands out in India's expanding healthcare contract manufacturing space with strong financials, consistent profitability, and minimal debt. Its strategic position in the CDMO segment, multiple manufacturing facilities, and experienced leadership enhance investor confidence.

Reasonable valuation and rising demand for pharmaceutical and cosmetics outsourcing further strengthen its appeal. For investors eyeing long-term growth in healthcare manufacturing, this IPO presents a solid opportunity.

Want to analyze stocks in detail? Sign up for Dhanarthi a free platform offering quick access to company ratios, earnings call data, and performance metrics to help you invest smarter.

Disclaimer : This analysis is for educational purposes only and should not be considered as financial advice. Please consult with your financial advisor before making any investment decisions. SME investments carry higher risks compared to mainboard stocks.